Advocating biomarker-guided perioperative hydrocortisone therapy to reduce morbidity after pancreatoduodenectomy
Crossref DOI link: https://doi.org/10.1007/s13304-025-02391-y
Published Online: 2025-08-27
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Shah, Muhammad Zahir https://orcid.org/0009-0002-4667-3131
Ullah, Azmat
Talha, Abu
Text and Data Mining valid from 2025-08-27
Version of Record valid from 2025-08-27
Article History
Received: 25 July 2025
Accepted: 18 August 2025
First Online: 27 August 2025
Declarations
:
: The authors declare that they have no conflicts of interest.
: This work doesn't involve human/animal participation.
: Not applicable.